Medtronic announces first patient enrolled in u.s. clinical trial for hugo™ robotic-assisted surgery system

Expand uro is a prospective, multi-center, single-arm study to evaluate the safety and performance of the hugo™ ras system for urologic procedures dublin , dec. 15, 2022 /prnewswire/ -- medtronic plc (nyse: mdt), a global healthcare technology leader, today announced the first patient enrolled in the expand uro u.s. clinical trial for the hugo™ robotic-assisted surgery (ras) system. the robotic-assisted prostatectomy procedure was performed by dr. michael r.
MDT Ratings Summary
MDT Quant Ranking